RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups

Advances in our understanding of the molecular biology of meningiomas have led to significant gains in the ability to predict patient prognosis and tumor recurrence and to identify novel targets for therapeutic design. Specifically, classification of meningiomas based on DNA methylation has greatly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Leclair, Nathan K. (VerfasserIn) , Choudury, Abrar (VerfasserIn) , Chen, William C (VerfasserIn) , Magill, Stephen T (VerfasserIn) , McCortney, Kathleen (VerfasserIn) , Horbinski, Craig M (VerfasserIn) , Chen, Zhenhong (VerfasserIn) , Goldschmidt, Ezequiel (VerfasserIn) , Eaton, Charlotte D (VerfasserIn) , Bulsara, Ketan R (VerfasserIn) , Bi, Wenya Linda (VerfasserIn) , Patel, Akash J (VerfasserIn) , Sahm, Felix (VerfasserIn) , Raleigh, David (VerfasserIn) , Anczukow, Olga (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: December 2024
In: Neuro-Oncology
Year: 2024, Jahrgang: 26, Heft: 12, Pages: 2222-2236
ISSN:1523-5866
DOI:10.1093/neuonc/noae150
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1093/neuonc/noae150
Volltext
Verfasserangaben:Nathan K. Leclair, Abrar Choudury, William C. Chen, Stephen T. Magill, Kathleen McCortney, Craig M. Horbinski, Zhenhong Chen, Ezequiel Goldschmidt, Charlotte D. Eaton, Ketan R. Bulsara, Wenya Linda Bi, Akash J. Patel, Felix Sahm, David Raleigh, and Olga Anczukow

MARC

LEADER 00000naa a2200000 c 4500
001 1929861680
003 DE-627
005 20250707112102.0
007 cr uuu---uuuuu
008 250707s2024 xx |||||o 00| ||eng c
024 7 |a 10.1093/neuonc/noae150  |2 doi 
035 |a (DE-627)1929861680 
035 |a (DE-599)KXP1929861680 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Leclair, Nathan K.  |e VerfasserIn  |0 (DE-588)1370846843  |0 (DE-627)192986339X  |4 aut 
245 1 0 |a RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups  |c Nathan K. Leclair, Abrar Choudury, William C. Chen, Stephen T. Magill, Kathleen McCortney, Craig M. Horbinski, Zhenhong Chen, Ezequiel Goldschmidt, Charlotte D. Eaton, Ketan R. Bulsara, Wenya Linda Bi, Akash J. Patel, Felix Sahm, David Raleigh, and Olga Anczukow 
264 1 |c December 2024 
300 |b Illustrationen 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 02 August 2024 
500 |a Gesehen am 07.07.2025 
520 |a Advances in our understanding of the molecular biology of meningiomas have led to significant gains in the ability to predict patient prognosis and tumor recurrence and to identify novel targets for therapeutic design. Specifically, classification of meningiomas based on DNA methylation has greatly improved our ability to risk stratify patients, however new questions have arisen in terms of the underlying impact these DNA-methylation signatures have on meningioma biology.This study utilizes RNA-sequencing data from 486 meningioma samples corresponding to 3 meningioma DNA-methylation groups (merlin-intact, immune-enriched, and hypermitotic), followed by in vitro experiments utilizing human meningioma cell lines.We identify alterations in RNA splicing between meningioma DNA-methylation groups including individual splicing events that correlate with hypermitotic meningiomas and predict tumor recurrence and overall patient prognosis and compile a set of splicing events that can accurately predict DNA-methylation classification based on RNA-seq data. Furthermore, we validate these events using reverse transcription polymerase chain reaction (RT-PCR) in patient samples and meningioma cell lines. Additionally, we identify alterations in RNA-binding proteins and splicing factors that lie upstream of RNA splicing events, including upregulation of SRSF1 in hypermitotic meningiomas which we show drives alternative RNA splicing changes. Finally, we design splice-switching antisense oligonucleotides to target RNA splicing changes in NASP and MFF observed in hypermitotic meningiomas, providing a rationale for RNA-based therapeutic design.RNA splicing is an important driver of meningioma phenotypes that can be useful in prognosticating patients and as a potential exploit for therapeutic vulnerabilities. 
700 1 |a Choudury, Abrar  |e VerfasserIn  |4 aut 
700 1 |a Chen, William C  |e VerfasserIn  |4 aut 
700 1 |a Magill, Stephen T  |e VerfasserIn  |4 aut 
700 1 |a McCortney, Kathleen  |e VerfasserIn  |4 aut 
700 1 |a Horbinski, Craig M  |e VerfasserIn  |4 aut 
700 1 |a Chen, Zhenhong  |e VerfasserIn  |4 aut 
700 1 |a Goldschmidt, Ezequiel  |e VerfasserIn  |4 aut 
700 1 |a Eaton, Charlotte D  |e VerfasserIn  |4 aut 
700 1 |a Bulsara, Ketan R  |e VerfasserIn  |4 aut 
700 1 |a Bi, Wenya Linda  |e VerfasserIn  |4 aut 
700 1 |a Patel, Akash J  |e VerfasserIn  |4 aut 
700 1 |a Sahm, Felix  |d 1984-  |e VerfasserIn  |0 (DE-588)1022852132  |0 (DE-627)717318478  |0 (DE-576)366075020  |4 aut 
700 1 |a Raleigh, David  |e VerfasserIn  |4 aut 
700 1 |a Anczukow, Olga  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Neuro-Oncology  |d Oxford : Oxford Univ. Press, 1999  |g 26(2024), 12 vom: Dez., Seite 2222-2236  |h Online-Ressource  |w (DE-627)357167341  |w (DE-600)2094060-9  |w (DE-576)318041839  |x 1523-5866  |7 nnas  |a RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups 
773 1 8 |g volume:26  |g year:2024  |g number:12  |g month:12  |g pages:2222-2236  |g extent:15  |a RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups 
856 4 0 |u https://doi.org/10.1093/neuonc/noae150  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250707 
993 |a Article 
994 |a 2024 
998 |g 1022852132  |a Sahm, Felix  |m 1022852132:Sahm, Felix  |d 910000  |d 912000  |d 50000  |e 910000PS1022852132  |e 912000PS1022852132  |e 50000PS1022852132  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 13 
999 |a KXP-PPN1929861680  |e 4743551056 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1929861680"],"doi":["10.1093/neuonc/noae150"]},"name":{"displayForm":["Nathan K. Leclair, Abrar Choudury, William C. Chen, Stephen T. Magill, Kathleen McCortney, Craig M. Horbinski, Zhenhong Chen, Ezequiel Goldschmidt, Charlotte D. Eaton, Ketan R. Bulsara, Wenya Linda Bi, Akash J. Patel, Felix Sahm, David Raleigh, and Olga Anczukow"]},"physDesc":[{"noteIll":"Illustrationen","extent":"15 S."}],"recId":"1929861680","note":["Veröffentlicht: 02 August 2024","Gesehen am 07.07.2025"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups","title":"RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups"}],"relHost":[{"recId":"357167341","physDesc":[{"extent":"Online-Ressource"}],"disp":"RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groupsNeuro-Oncology","origin":[{"dateIssuedKey":"1999","publisherPlace":"Oxford ; Durham, NC","dateIssuedDisp":"1999-","publisher":"Oxford Univ. Press ; Duke University Medical Center"}],"pubHistory":["1.1999 -"],"id":{"zdb":["2094060-9"],"eki":["357167341"],"issn":["1523-5866"]},"title":[{"subtitle":"official journal of the World Federation of Neuro-Oncology","title":"Neuro-Oncology","title_sort":"Neuro-Oncology"}],"part":{"volume":"26","year":"2024","extent":"15","text":"26(2024), 12 vom: Dez., Seite 2222-2236","issue":"12","pages":"2222-2236"},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 21.07.23"]}],"person":[{"display":"Leclair, Nathan K.","given":"Nathan K.","role":"aut","family":"Leclair"},{"given":"Abrar","role":"aut","family":"Choudury","display":"Choudury, Abrar"},{"display":"Chen, William C","role":"aut","given":"William C","family":"Chen"},{"display":"Magill, Stephen T","family":"Magill","role":"aut","given":"Stephen T"},{"given":"Kathleen","role":"aut","family":"McCortney","display":"McCortney, Kathleen"},{"display":"Horbinski, Craig M","given":"Craig M","role":"aut","family":"Horbinski"},{"display":"Chen, Zhenhong","family":"Chen","role":"aut","given":"Zhenhong"},{"display":"Goldschmidt, Ezequiel","role":"aut","given":"Ezequiel","family":"Goldschmidt"},{"given":"Charlotte D","role":"aut","family":"Eaton","display":"Eaton, Charlotte D"},{"role":"aut","given":"Ketan R","family":"Bulsara","display":"Bulsara, Ketan R"},{"role":"aut","given":"Wenya Linda","family":"Bi","display":"Bi, Wenya Linda"},{"family":"Patel","role":"aut","given":"Akash J","display":"Patel, Akash J"},{"display":"Sahm, Felix","family":"Sahm","role":"aut","given":"Felix"},{"family":"Raleigh","given":"David","role":"aut","display":"Raleigh, David"},{"role":"aut","given":"Olga","family":"Anczukow","display":"Anczukow, Olga"}],"origin":[{"dateIssuedDisp":"December 2024","dateIssuedKey":"2024"}]} 
SRT |a LECLAIRNATRNASPLICIN2024